OneMedNet Corp reported modest revenue with persistent net losses in its latest annual filing, underscoring ongoing financial pressures. The company remains focused on regaining Nasdaq compliance following a notification on its common stock bid price, exploring potential reverse splits as remedial measures. Its core business leverages a specialized healthcare data sharing platform aimed at real-world patient data access, serving AI development and healthcare analytics in a competitive and regulated market. Key growth levers include expanding multimodal data partnerships and enterprise sales initiatives, while risks center on regulatory compliance challenges and constrained financial liquidity.